Skip to main content
HTFL
NASDAQ Industrial Applications And Services

Heartflow Q2 Revenue Jumps 48%, Raises Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$31.78
Mkt Cap
$2.674B
52W Low
$20.13
52W High
$41.223
52W Position info
58% above low
Off High info
23% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

HTFL sits 58% above its 52-week low of $20.13.

Summary

Heartflow reported Q2 revenue of $64.1M, up 48% YoY, and raised full-year guidance to $246-$250M. Gross margin expanded to 83% and cash stands at $246.8M.


Key Events · Earnings and Guidance · HTFL

  • Q2 Revenue Up 48%

    Total revenue reached $64.1 million, a 48% increase year-over-year, driven by higher FFR CT and Plaque case volumes.

  • Full-Year Guidance Raised

    Management raised 2026 revenue guidance to $246-$250 million (40-42% growth) from $228-$232 million, and non-GAAP gross margin guidance to ~82% from ~81%.

  • Gross Margin Expansion

    Gross margin improved to 83.0% from 75.5% a year ago, reflecting higher case volume and AI-driven productivity gains.

  • Loss Narrows on Non-GAAP Basis

    Non-GAAP net operating loss narrowed to $7.9 million from $11.5 million; GAAP net loss was $15.7 million ($0.18/share).


Analysis · HTFL · Industrial Applications And Services

A standout quarter for Heartflow, with revenue climbing 48% year-over-year to $64.1 million on the back of higher FFR CT and Plaque case volumes. Management lifted full-year revenue guidance to $246-$250 million, implying 40-42% growth, up from the prior $228-$232 million range. Gross margin expanded to 83.0% from 75.5% a year ago, and the non-GAAP operating loss narrowed to $7.9 million from $11.5 million. The company remains unprofitable on a GAAP basis with a net loss of $15.7 million, but holds $246.8 million in cash and investments, providing ample runway. This is a notable positive update for a company that has seen consistent insider selling over the past 90 days.

How filings like this one have moved

In the 30 days to Oct 19, 2026, 29.4% of the 1387 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.51%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HTFL was trading at $31.78 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $20.13 to $41.22. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HTFL - Latest Insights

HTFL
Aug 28, 2026, 2:48 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $48.26
Real-time Price: $48.35 info
Change: +$0.090 (+0.19%) info
Market Cap: $4.199B info
HTFL
Aug 14, 2026, 4:58 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.88
Real-time Price: $48.35 info
Change: +$6.47 (+15%) info
Market Cap: $4.199B info
HTFL
Aug 14, 2026, 3:47 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $41.88
Real-time Price: $48.35 info
Change: +$6.47 (+15%) info
Market Cap: $4.199B info
HTFL
Aug 14, 2026, 3:29 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $42.16
Real-time Price: $48.35 info
Change: +$6.19 (+15%) info
Market Cap: $4.199B info
HTFL
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.97
Real-time Price: $48.35 info
Change: +$12.38 (+34%) info
Market Cap: $4.199B info